Levels of adiponectin and leptin at onset of type 1 diabetes have changed over time in children and adolescents

Acta Diabetologica

Volumn 52, Issue 1, 2015, Pages 167-174

  Safai, Narges ^a   Eising, Stefanie ^b   Hougaard, David Michael ^c   Mortensen, Henrik Bindesbøl ^d   Skogstrand, Kristin ^c   Pociot, Flemming ^d   Johannesen, Jesper ^d   Svensson, Jannet ^d  

^a STENO DIABETES CENTER   (Denmark)

^b Hørup Lægehus ^*  (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adipocytokines; Adipose tissue biology; Diabetes in childhood; Pathophysiology

Indexed keywords

ADIPONECTIN; INSULIN; LEPTIN;

ADOLESCENT; AGE; BLOOD; BODY MASS; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMAN; INFANT; INSULIN RESISTANCE; MALE; ONSET AGE; PRESCHOOL CHILD; TIME;

ADIPONECTIN; ADOLESCENT; AGE FACTORS; AGE OF ONSET; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFANT; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; TIME FACTORS;

EID: 84939878994     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0630-y     Document Type: Article

References (42)

1. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J (1999) Worldwide increase in incidence of Type I diabetes—the analysis of the data on published incidence trends. Diabetologia 42(12):1395–1403. doi:10.1007/s001250051309
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257(1):79–83
3. Lihn AS, Pedersen SB, Richelsen B (2005) Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 6(1):13–21. doi:10.1111/j.1467-789X.2005.00159.x
4. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H (2004) Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323(2):630–635. doi:10.1016/j.bbrc.2004.08.145
5. Shimada K, Miyazaki T, Daida H (2004) Adiponectin and atherosclerotic disease. Clin Chim Acta 344(1–2):1–12. doi:10.1016/j.cccn.2004.02.020
6. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S (2005) Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288(5):H2031–H2041. doi:10.1152/ajpheart.01058.2004
7. Koerner A, Kratzsch J, Kiess W (2005) Adipocytokines: leptin–the classical, resistin–the controversical, adiponectin–the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19(4):525–546. doi:10.1016/j.beem.2005.07.008
8. Huerta MG (2006) Adiponectin and leptin: potential tools in the differential diagnosis of pediatric diabetes? Rev Endocr Metab Disord 7(3):187–196. doi:10.1007/s11154-006-9017-x
9. Fernandez-Riejos P, Najib S, Santos-Alvarez J, Martin-Romero C, Perez-Perez A, Gonzalez-Yanes C, Sanchez-Margalet V (2010) Role of leptin in the activation of immune cells. Mediators Inflamm 2010:568343. doi:10.1155/2010/568343
10. Svensson J, Eising S, Hougaard DM, Mortensen HB, Skogstrand K, Simonsen LB, Carstensen B, Nilsson A, Lernmark A, Pociot F, Johannesen J (2012) Few differences in cytokines between patients newly diagnosed with type 1 diabetes and their healthy siblings. Hum Immunol 73(11):1116–1126. doi:10.1016/j.humimm.2012.07.337
11. Brorsson C, Vaziri-Sani F, Bergholdt R, Eising S, Nilsson A, Svensson J, Lernmark A, Pociot F (2011) Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes. Autoimmunity 44(2):107–114. doi:10.3109/08916934.2010.509120
12. Nysom K, Molgaard C, Michaelsen KF, Hutchings B, Andersen E (2002) Body mass index. Reference values for 0–45-year-old Danes. Ugeskr Laeger 164(49):5773–5777
13. Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, Hougaard DM (2005) Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 51(10):1854–1866. doi:10.1373/clinchem.2005.052241
14. Nielsen LB, Vaziri-Sani F, Porksen S, Andersen ML, Svensson J, Bergholdt R, Pociot F, Hougaard P, de Beaufort C, Castano L, Mortensen HB, Lernmark A, Hansen L (2011) Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes. Autoimmunity 44(8):616–623. doi:10.3109/08916934.2011.576724
15. Rolland-Cachera MF, Castetbon K, Arnault N, Bellisle F, Romano MC, Lehingue Y, Frelut ML, Hercberg S (2002) Body mass index in 7–9-y-old French children: frequency of obesity, overweight and thinness. Int J Obes Relat Metab Disord 26(12):1610–1616. doi:10.1038/sj.ijo.0802146
16. Lobstein TJ, James WP, Cole TJ (2003) Increasing levels of excess weight among children in England. Int J Obes Relat Metab Disord 27(9):1136–1138. doi:10.1038/sj.ijo.0802324
17. Reilly JJ, Dorosty AR (1999) Epidemic of obesity in UK children. Lancet 354(9193):1874–1875. doi:10.1016/S0140-6736(99)04555-9
18. Zimmermann MB, Gubeli C, Puntener C, Molinari L (2004) Detection of overweight and obesity in a national sample of 6–12-y-old Swiss children: accuracy and validity of reference values for body mass index from the US Centers for Disease Control and Prevention and the International Obesity Task Force. Am J Clin Nutr 79(5):838–843
19. Ogden CL, Flegal KM, Carroll MD, Johnson CL (2002) Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA 288(14):1728–1732
20. Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. JAMA 307(5):483–490. doi:10.1001/jama.2012.40
21. Celi F, Bini V, Papi F, Santilli E, Castellani MS, Ferretti A, Mencacci M, Berioli MG, De Giorgi G, Falorni A (2006) Circulating adipocytokines in non-diabetic and Type 1 diabetic children: relationship to insulin therapy, glycaemic control and pubertal development. Diabet Med 23(6):660–665. doi:10.1111/j.1464-5491.2006.01823.x
22. Morales A, Wasserfall C, Brusko T, Carter C, Schatz D, Silverstein J, Ellis T, Atkinson M (2004) Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care 27(8):2010–2014
23. Ahmed ML, Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB (2001) Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J Clin Endocrinol Metab 86(3):1188–1193
24. Galler A, Gelbrich G, Kratzsch J, Noack N, Kapellen T, Kiess W (2007) Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study. Eur J Endocrinol 157(4):481–489. doi:10.1530/EJE-07-0250
25. Larsen LM, Hertel NT, Molgaard C, Christensen R, Husby S, Jarbol DE (2012) Prevalence of overweight and obesity in Danish preschool children over a 10-year period: a study of two birth cohorts in general practice. Acta Paediatr 101(2):201–207. doi:10.1111/j.1651-2227.2011.02551.x
26. Salbe AD, Nicolson M, Ravussin E (1997) Total energy expenditure and the level of physical activity correlate with plasma leptin concentrations in five-year-old children. J Clin Investig 99(4):592–595. doi:10.1172/JCI119200
27. Sartorius T, Heni M, Tschritter O, Preissl H, Hopp S, Fritsche A, Lievertz PS, Gertler A, Berthou F, Taouis M, Staiger H, Haring HU, Hennige AM (2012) Leptin affects insulin action in astrocytes and impairs insulin-mediated physical activity. Cell Physiol Biochem 30(1):238–246. doi:10.1159/000339060
28. Tjonna AE, Stolen TO, Bye A, Volden M, Slordahl SA, Odegard R, Skogvoll E, Wisloff U (2009) Aerobic interval training reduces cardiovascular risk factors more than a multitreatment approach in overweight adolescents. Clin Sci (Lond) 116(4):317–326. doi:10.1042/CS20080249
29. Simpson KA, Singh MA (2008) Effects of exercise on adiponectin: a systematic review. Obesity (Silver Spring) 16(2):241–256. doi:10.1038/oby.2007.53
30. Silva FM, de Almeida JC, Feoli AM (2011) Effect of diet on adiponectin levels in blood. Nutr Rev 69(10):599–612. doi:10.1111/j.1753-4887.2011.00414.x
31. Murakami K, Sasaki S, Takahashi Y, Uenishi K, Yamasaki M, Hayabuchi H, Goda T, Oka J, Baba K, Ohki K, Watanabe R, Sugiyama Y (2007) Nutrient and food intake in relation to serum leptin concentration among young Japanese women. Nutrition 23(6):461–468. doi:10.1016/j.nut.2007.04.006
32. Santos S, Oliveira A, Lopes C (2013) Systematic review of saturated fatty acids on inflammation and circulating levels of adipokines. Nutr Res 33(9):687–695. doi:10.1016/j.nutres.2013.07.002
33. Kirel B, Dogruel N, Korkmaz U, Kilic FS, Ozdamar K, Ucar B (2000) Serum leptin levels in type 1 diabetic and obese children: relation to insulin levels. Clin Biochem 33(6):475–480
34. Martos-Moreno GA, Barrios V, Soriano-Guillen L, Argente J (2006) Relationship between adiponectin levels, acylated ghrelin levels, and short-term body mass index changes in children with diabetes mellitus type 1 at diagnosis and after insulin therapy. Eur J Endocrinol 155(5):757–761. doi:10.1530/eje.1.02273
35. Hanaki K, Becker DJ, Arslanian SA (1999) Leptin before and after insulin therapy in children with new-onset type 1 diabetes. J Clin Endocrinol Metabolism 84(5):1524–1526
36. McCormick KL, Mick GJ, Butterfield L, Ross H, Parton E, Totka J (2001) Leptin in children with newly diagnosed type 1 diabetes: effect of insulin therapy. Int J Exp Diabetes Res 2(2):121–127
37. Barnes MM, Curran-Everett D, Hamman RF, Maahs D, Mayer-Davis EJ, D’Agostino RB Jr, West N, Dabelea D (2008) Determinants of adiponectin levels in young people with Type 1 diabetes. Diabet Med 25(3):365–369. doi:10.1111/j.1464-5491.2007.02374.x
38. Abd El-Maksoud AM, El Hefnawy MH, Abdel-Ghaffar AR, Eskander EF, Ahmed HH, Seoudi DM, Yahya SM, Kamal IH (2009) Adiponectin, leptin, and lipid profile in type 1 diabetic children and adolescents. J Clin Lipidol 3(4):269–274. doi:10.1016/j.jacl.2009.07.002
39. Kratzsch J, Knerr I, Galler A, Kapellen T, Raile K, Korner A, Thiery J, Dotsch J, Kiess W (2006) Metabolic decompensation in children with type 1 diabetes mellitus associated with increased serum levels of the soluble leptin receptor. Eur J Endocrinol 155(4):609–614. doi:10.1530/eje.1.02261
40. Kaas A, Pfleger C, Hansen L, Buschard K, Schloot NC, Roep BO, Mortensen HB (2010) Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis. Clin Exp Immunol 161(3):444–452. doi:10.1111/j.1365-2249.2010.04193.x
41. Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E, Bluher M, Kiess W (2004) Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89(8):4053–4061. doi:10.1210/jc.2004-0303
42. Svensson J, Lyngaae-Jorgensen A, Carstensen B, Simonsen LB, Mortensen HB (2009) Long-term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time. Pediatr Diabetes 10(4):248–254. doi:10.1111/j.1399-5448.2008.00483.x